Toei Shinyaku Obtains Japanese Patent Based on Agaricus KA21 Research Related to Stress-Induced Cognitive Dysfunction

Toei Shinyaku Co., Ltd. has obtained a Japanese patent based on collaborative research with Shigakkan University investigating outdoor-cultivated Agaricus KA21 in relation to stress-induced cognitive dysfunction.

The research was conducted jointly with Shigakkan Educational Foundation, including Shigakkan University (Obu, Aichi, Japan), with Professor Takanori Tada of the Faculty of Health Science as a collaborating researcher.

The patent represents an intellectual property outcome of Toei Shinyaku’s continuing scientific research on outdoor-cultivated Agaricus KA21.

Patent Details

Patent Number: Japanese Patent No. 7752340
Patent Application Number: 2022-174395
Filing Date: October 31, 2022
Registration Date: October 2, 2025
Inventors: Takanori Tada, Akitomo Motoi
Applicants: Toei Shinyaku Co., Ltd.; Shigakkan Educational Foundation

The patented research concerns Agaricus KA21 in relation to cognitive dysfunction caused by stress.

Toei Shinyaku has conducted research on outdoor-cultivated Agaricus KA21 for more than 30 years and continues to build scientific evidence through collaborative research with universities and research institutions.

Agaricus KA21 is derived from outdoor-cultivated Agaricus brasiliensis and is commercially known as King Agaricus KA21.

Press Releases

English:
https://en.atpress.com/news/550551

Japanese:
https://www.atpress.ne.jp/news/550551

Simplified Chinese:
https://zh.atpress.com/news/550551

Patent